InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Mackin James P, Chief Executive Officer. Insider active across 2 companies, notably CRYOLIFE INC. Cumulatively, 12 reports have been recorded. The latest transaction was filed on 5 March 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Declarations12 total
€211,69010,801 shares@ €19.59910.019% mcap24.2% of flow
Common Stock
SEC:0000784199-22-000112:0·
047,627 shares0
Common Stock
SEC:0000784199-22-000092:0·
€50,0343,204 shares@ €15.61610.0045% mcap5.7% of flow
Common Stock
SEC:0000784199-22-000072:0·
036,404 shares0
Common Stock
SEC:0000784199-22-000050:0·
€102,45610,638 shares@ €9.631233.4% of flow
Common Stock
SEC:0000784199-22-000030·
€102,45610,638 shares@ €9.63120.0093% mcap11.7% of flow
Common Stock
SEC:0000784199-22-000030:0·
€102,26210,638 shares@ €9.612933.3% of flow
Common Stock
SEC:0000784199-22-000018·
€102,26210,638 shares@ €9.61290.0093% mcap11.7% of flow
Common Stock
SEC:0000784199-22-000018:0·
€102,15310,638 shares@ €9.602733.3% of flow
Common Stock
SEC:0000784199-22-000016·
€102,15310,638 shares@ €9.60270.0092% mcap11.7% of flow
Common Stock
SEC:0000784199-22-000016:0·
€136,53516,265 shares@ €8.3944100.0% of flow
Common Stock
SEC:0000784199-21-000123·
€136,53516,265 shares@ €8.394450.0% of flow
Common Stock
SEC:0000784199-21-000123:0·
12 of 12 declarations
About Mackin James P
James P. Mackin serves as President and CEO of CryoLife Inc and Artivion, Inc. He is responsible for the strategic and operational leadership of both companies, ensuring the implementation of initiatives aimed at achieving growth objectives. James plays a key role in developing new medical solutions to meet market needs.
